Back to results
US 2019/0160121 A1Published application
Novel vibrio parahaemolyticus bacteriophage vib-pap-5 and use thereof for suppressing proliferation of vibrio parahaemolyticus bacteria
AssigneeIntron Biotechnology, Inc.
InventorsSeong Jun Yoon, Sang Hyeon Kang, Soo Youn Jun, An Sung Kwon
Life of this patent
Estimating the term…
Abstract
The present invention relates to a Myoviridae bacteriophage Vib-PAP-5 (accession number KCTC 13029BP) isolated from nature characterized by having a capability for specifically killing Vibrio parahaemolyticus bacteria and having a genome expressed by the SEQ ID NO:1, and to a method for preventing and treating infections from Vibrio parahaemolyticus bacteria by means of a composition comprising the Myoviridae bacteriophage Vib-PAP-5 as an active ingredient.
Claims5
A Myoviridae bacteriophage Vib-PAP-5 (Accession number:
- KCTC 13029BP) isolated from nature, which has an ability to specifically kill Vibrio parahaemolyticus and which includes a genome expressed by a SEQ. ID. NO:
- 1.
Dependencies are inferred from the claim text.